Toxicity of WR-2721 administered in single and multiple doses
Authors:
- Morton M. KligermanMKMorton M. Kligerman
- Donna J. GloverDGDonna J. Glover
- Andrew T. TurrisiATAndrew T. Turrisi
- A.LOrraine NorfleetANA.LOrraine Norfleet
- John M. YuhasJYJohn M. Yuhas
- Lawrence R. CoiaLCLawrence R. Coia
- Charles SimoneCSCharles Simone
- John H. GlickJGJohn H. Glick
- Robert L. GoodmanRGRobert L. Goodman
- 1 September 1984
- journal article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 10 (9) , 1773-1776
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Hypocalcemia and Inhibition of Parathyroid Hormone Secretion after Administration of WR-2721 (a Radioprotective and Chemoprotective Agent)New England Journal of Medicine, 1983
- The modification of melphalan toxicity in tumor bearing mice by S-2-(3-aminopropylamino)-ethylphosphorothioic acid (WR2721)American Journal of Clinical Oncology, 1982
- Clinical trials of WR-2721 with radiation therapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1982